Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:342-343 (9 August), doi:10.1136/bmj.327.7410.342-c
| The first 150 words of the full text of this article appear below. |
EDITORMany of the 100 plus contributors to the editorial by Abbasi and Smith were indignant.1 Wasn't it stating the obvious? Clearly drug companies would not spend vast sums on persuading doctors to prescribe their drugs if they didn't think these tactics paid off. But doctors are more than capable of resisting the blandishments of drug company sales representatives and seeing through the inducements of lavish corporate hospitality, they contended.
Disentanglement from drug companies whiffed of utopian sanctimoniousness,
others fumed, and ignored both the realities of working in the NHSwhere
continuing medical education languishes at the back of the financial
priorities queueand the inevitability of a profit driven, commercial
world. It's a question of "mindful practice" suggested one
correspondent. And many felt the several pages of advertisements in the
BMJ, paid for by drug companies, smacked of hypocrisy and blasted a
large crater in the arguments favouring greater
Caroline White, freelance medical writer
London E17 4SQ